STOCK TITAN

Transcat Financials

TRNS
Trailing 12 months to June 27, 2026
Revenue $348.4M +20.9% YoY
Net Income $3.4M -74.2% YoY
EPS (Diluted) $0.36 -74.8% YoY
Free Cash Flow $25.4M YoY not available
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2027, ended Jun 27, 2026 Reported Currency USD FYE March

Transcat (TRNS) reported $348.4M in revenue over the twelve months to Jun 27, 2026, up 20.9% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI TRNS FY2026

Acquisition-led growth is expanding revenue, but below-gross-line costs and higher borrowing are absorbing much of the gain.

Acquisition-heavy expansion is visible in the balance sheet: goodwill rose from $105.6M to $218.2M, showing that much of asset growth came through deals rather than internally built capacity. That shift helps reconcile weaker earnings with steadier cash: operating cash flow was $34.9M while net income was only $5.4M, because acquired intangibles add non-cash amortization and the larger debt load now claims more profit below operating income.

The gross-profit layer held up — gross margin reached 32.6% — which suggests direct service costs remained controlled even as scale increased. That is why revenue reached $331.9M while operating income was only $13.3M; the pressure sits below gross profit rather than in direct service costs.

The company still shows comfortable short-term liquidity with a current ratio of 2.3x, but recent expansion is being financed with a meaningfully heavier capital structure than before. Debt climbed to $99.9M while cash was just $4.9M, which leaves less room for acquisitions or integration missteps to be funded internally.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 56 / 100
Financial Health Score 56/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Transcat's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
62

Transcat has an operating margin of 4.0%, meaning the company retains $4 of operating profit per $100 of revenue. This results in a moderate score of 62/100, indicating healthy but not exceptional operating efficiency. This is down from 6.4% the prior year.

Growth
72

Transcat's revenue surged 19.2% year-over-year to $331.9M, reflecting rapid business expansion. This strong growth earns a score of 72/100.

Leverage
26

Transcat has elevated debt relative to equity (D/E of 0.33), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 26/100, reflecting increased financial risk.

Liquidity
65

With a current ratio of 2.33, Transcat holds $2.33 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 65/100.

Cash Flow
57

Transcat has a free cash flow margin of 5.9%, earning a moderate score of 57/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
54

Transcat's ROE of 1.8% shows moderate profitability relative to equity, earning a score of 54/100. This is down from 5.1% the prior year.

Altman Z-Score Safe
4.00

Transcat scores 4.00, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($839.2M) relative to total liabilities ($179.9M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
5/9

Transcat passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 1 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
6.48x

For every $1 of reported earnings, Transcat generates $6.48 in operating cash flow ($34.9M OCF vs $5.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Adequate
2.88x

Transcat earns $2.88 in operating income for every $1 of interest expense ($13.3M vs $4.6M). This adequate coverage means the company can meet its interest obligations, but has limited cushion if earnings fall.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$331.9M
YoY+19.2%
5Y CAGR+13.9%
10Y CAGR+10.5%

Transcat generated $331.9M in revenue in fiscal year 2026. This represents an increase of 19.2% from the prior year.

EBITDA
$39.4M
YoY+8.2%
5Y CAGR+16.2%
10Y CAGR+14.4%

Transcat's EBITDA was $39.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 8.2% from the prior year.

Net Income
$5.4M
YoY-63.0%
5Y CAGR-7.2%
10Y CAGR+2.7%

Transcat reported $5.4M in net income in fiscal year 2026. This represents a decrease of 63.0% from the prior year.

EPS (Diluted)
$0.57
YoY-63.7%
5Y CAGR-11.2%
10Y CAGR-0.2%

Transcat earned $0.57 per diluted share (EPS) in fiscal year 2026. This represents a decrease of 63.7% from the prior year.

Cash & Balance Sheet

Free Cash Flow
$19.6M
YoY-24.2%
5Y CAGR+2.8%
10Y CAGR+11.0%

Transcat generated $19.6M in free cash flow in fiscal year 2026, representing cash available after capex. This represents a decrease of 24.2% from the prior year.

Cash & Debt
$4.9M
YoY+225.8%
5Y CAGR+54.6%
10Y CAGR+22.7%

Transcat held $4.9M in cash against $99.9M in long-term debt as of fiscal year 2026.

Shares Outstanding
9M
YoY+0.2%
5Y CAGR+4.6%
10Y CAGR+3.0%

Transcat had 9M shares outstanding in fiscal year 2026. This represents an increase of 0.2% from the prior year.

Dividends Per Share

Not reported for fiscal year 2026.

Margins & Returns

Gross Margin
32.6%
YoY+0.5pp
5Y CAGR+6.0pp
10Y CAGR+8.8pp

Transcat's gross margin was 32.6% in fiscal year 2026, indicating the percentage of revenue retained after direct costs. This is up 0.5 percentage points from the prior year.

Operating Margin
4.0%
YoY-2.4pp
5Y CAGR-2.4pp
10Y CAGR-1.2pp

Transcat's operating margin was 4.0% in fiscal year 2026, reflecting core business profitability. This is down 2.4 percentage points from the prior year.

Net Margin
1.6%
YoY-3.6pp
5Y CAGR-2.9pp
10Y CAGR-1.8pp

Transcat's net profit margin was 1.6% in fiscal year 2026, showing the share of revenue converted to profit. This is down 3.6 percentage points from the prior year.

Return on Equity
1.8%
YoY-3.3pp
5Y CAGR-8.6pp
10Y CAGR-8.8pp

Transcat's ROE was 1.8% in fiscal year 2026, measuring profit generated per dollar of shareholder equity. This is down 3.3 percentage points from the prior year.

Capital Allocation

Share Buybacks
$469K
YoY-86.8%
5Y CAGR-31.2%
10Y CAGR+20.4%

Transcat spent $469K on share buybacks in fiscal year 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 86.8% from the prior year.

Capital Expenditures
$15.3M
YoY+15.9%
5Y CAGR+18.2%
10Y CAGR+14.1%

Transcat invested $15.3M in capex in fiscal year 2026, funding long-term assets and infrastructure. This represents an increase of 15.9% from the prior year.

R&D Spending

Not reported for fiscal year 2026.

TRNS Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TRNS quarterly income statement
MetricQ1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25
Revenue$92.9M+4.1%$89.3M+6.5%$83.9M+1.9%$82.3M+7.7%$76.4M-0.9%$77.1M+15.5%$66.8M-1.6%$67.8M
Cost of Revenue$62.2M+5.7%$58.9M+0.4%$58.6M+5.6%$55.5M+9.7%$50.6M-1.2%$51.2M+8.8%$47.1M+1.0%$46.6M
Gross Profit$30.7M+0.9%$30.5M+20.7%$25.3M-5.6%$26.8M+3.6%$25.8M-0.4%$25.9M+31.7%$19.7M-7.2%$21.2M
SG&A Expenses$15.6M+4.9%$14.9M+8.3%$13.8M+9.0%$12.6M+15.2%$11.0M+12.7%$9.7M+2.9%$9.5M+1.8%$9.3M
Operating Income$3.7M-14.2%$4.3M+4822.7%$88K-97.5%$3.5M-34.3%$5.3M-23.1%$6.9M+230.5%$2.1M-43.8%$3.7M
Interest Expense$1.5M+10.1%$1.4M-8.3%$1.5M+18.4%$1.3M+181.4%$451K-4.2%$471K+136.7%$199K+161.8%$76K
Income Tax$854K-3.7%$887K+362.4%-$338K-144.5%$760K-41.7%$1.3M-27.2%$1.8M+132.1%$772K+80.8%$427K
Net Income$1.3M-31.6%$1.9M+276.8%-$1.1M-186.8%$1.3M-61.1%$3.3M-26.9%$4.5M+89.4%$2.4M-28.3%$3.3M
EPS (Diluted)$0.14-30.0%$0.20+266.7%-$0.12-185.7%$0.14-60.0%$0.35-27.1%$0.48+92.0%$0.25-28.6%$0.35

Not reported in any period shown, so not listed: R&D Expenses.

TRNS Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TRNS quarterly balance sheet
MetricQ1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25
Total Assets$492.6M+2.5%$480.5M+1.6%$472.9M-2.5%$484.9M+23.5%$392.5M+1.9%$385.2M-0.2%$386.0M+19.3%$323.6M
Current Assets$95.7M+3.5%$92.5M+14.4%$80.8M-5.8%$85.7M+7.6%$79.7M+2.1%$78.0M+1.9%$76.6M-19.6%$95.2M
Cash & Equivalents$6.7M+35.8%$4.9M+42.4%$3.5M-31.7%$5.1M+173.1%$1.9M+22.7%$1.5M-67.3%$4.6M-80.5%$23.8M
Inventory$14.8M+7.8%$13.7M+6.1%$12.9M-1.2%$13.1M-15.1%$15.4M+6.3%$14.5M+5.0%$13.8M-11.3%$15.5M
Accounts Receivable$66.7M+2.4%$65.2M+10.9%$58.7M-6.1%$62.6M+8.5%$57.7M+3.1%$55.9M+8.4%$51.6M+5.5%$48.9M
Goodwill$226.8M+4.0%$218.2M0.0%$218.3M0.0%$218.4M+23.3%$177.1M+0.1%$176.9M+0.2%$176.6M+27.9%$138.1M
Total Liabilities$189.7M+5.5%$179.9M+2.1%$176.1M-7.0%$189.5M+89.5%$100.0M+1.7%$98.4M-6.3%$104.9M+91.5%$54.8M
Current Liabilities$38.4M-3.1%$39.6M+8.2%$36.6M+3.7%$35.3M+29.4%$27.3M-19.9%$34.0M+7.4%$31.7M+19.4%$26.5M
Long-Term Debt$110.4M+10.5%$99.9M0.0%$99.9M-10.7%$111.9M+237.2%$33.2M+7.4%$30.9M-21.8%$39.5M+6353.6%$612K
Total Equity$302.9M+0.8%$300.6M+1.3%$296.8M+0.5%$295.4M+1.0%$292.5M+2.0%$286.9M+2.1%$281.1M+4.6%$268.8M
Retained Earnings$98.8M+1.1%$97.8M+2.0%$95.8M-1.2%$97.0M+1.2%$95.8M+3.5%$92.5M+5.0%$88.1M+2.6%$85.9M

TRNS Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

TRNS quarterly cash flow statement
MetricQ1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25
Operating Cash Flow$8.8M+42.2%$6.2M-48.9%$12.1M-5.7%$12.9M+255.5%$3.6M-65.9%$10.6M-15.6%$12.6MN/A
Capital Expenditures$4.0M+11.0%$3.6M+34.0%$2.7M-39.6%$4.4M-3.6%$4.6M+70.6%$2.7M-6.1%$2.9MN/A
Free Cash Flow$4.8M+85.1%$2.6M-72.4%$9.5M+12.0%$8.4M+966.6%-$975K-112.3%$7.9M-18.5%$9.7MN/A
Investing Cash Flow-$16.8M-367.7%-$3.6M-34.1%-$2.7M+96.9%-$87.0M-1791.2%-$4.6M-13.9%-$4.0M+94.4%-$72.0MN/A
Financing Cash Flow$9.7M+2092.2%-$488K+96.0%-$12.2M-115.8%$77.2M+3869.6%$1.9M+120.6%-$9.4M-123.8%$39.7MN/A
Share Buybacks$1.9M+398.7%$372K+2761.5%-$13K-88.2%$110K$0-100.0%$357K+96.2%$182KN/A

Not reported in any period shown, so not listed: Dividends Paid.

TRNS Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

TRNS quarterly financial ratios
MetricQ1'27Q4'26Q3'26Q2'26Q1'26Q4'25Q3'25Q2'25
Gross Margin33.1%-1.0pp34.1%+4.0pp30.1%-2.4pp32.5%-1.3pp33.8%+0.2pp33.6%+4.1pp29.5%-1.8pp31.3%
Operating Margin4.0%-0.9pp4.9%+4.8pp0.1%-4.2pp4.3%-2.7pp7.0%-2.0pp9.0%+5.8pp3.1%-2.4pp5.5%
Net Margin1.4%-0.8pp2.2%+3.5pp-1.3%-2.9pp1.5%-2.7pp4.3%-1.5pp5.8%+2.3pp3.5%-1.3pp4.8%
Return on Equity0.4%-0.2pp0.7%+1.0pp-0.4%-0.8pp0.4%-0.7pp1.1%-0.4pp1.6%+0.7pp0.8%-0.4pp1.2%
Return on Assets0.3%-0.1pp0.4%+0.6pp-0.2%-0.5pp0.3%-0.6pp0.8%-0.3pp1.2%+0.5pp0.6%-0.4pp1.0%
Current Ratio2.49+0.2x2.33+0.1x2.21-0.2x2.43-0.5x2.92+0.6x2.29-0.1x2.42-1.2x3.59
Debt-to-Equity0.360.0x0.330.0x0.340.0x0.38+0.3x0.110.0x0.110.0x0.14+0.1x0.00
FCF Margin5.2%+2.3pp2.9%-8.4pp11.3%+1.0pp10.3%+11.6pp-1.3%-11.6pp10.3%-4.3pp14.6%N/A

Similar Companies

Frequently Asked Questions

What is Transcat's annual revenue?

Transcat (TRNS) reported $331.9M in total revenue for fiscal year 2026. This represents a 19.2% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Transcat's revenue growing?

Transcat (TRNS) revenue grew by 19.2% year-over-year, from $278.4M to $331.9M in fiscal year 2026.

Is Transcat profitable?

Yes, Transcat (TRNS) reported a net income of $5.4M in fiscal year 2026, with a net profit margin of 1.6%.

Transcat (TRNS) reported diluted earnings per share of $0.57 for fiscal year 2026. This represents a -63.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Transcat (TRNS) had EBITDA of $39.4M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, Transcat (TRNS) had $4.9M in cash and equivalents against $99.9M in long-term debt.

Transcat (TRNS) had a gross margin of 32.6% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Transcat (TRNS) had an operating margin of 4.0% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Transcat (TRNS) had a net profit margin of 1.6% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Transcat (TRNS) has a return on equity of 1.8% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Transcat (TRNS) generated $19.6M in free cash flow during fiscal year 2026. This represents a -24.2% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Transcat (TRNS) generated $34.9M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Transcat (TRNS) had $480.5M in total assets as of fiscal year 2026, including both current and long-term assets.

Transcat (TRNS) invested $15.3M in capital expenditures during fiscal year 2026, funding long-term assets and infrastructure.

Yes, Transcat (TRNS) spent $469K on share buybacks during fiscal year 2026, returning capital to shareholders by reducing shares outstanding.

Transcat (TRNS) had 9M shares outstanding as of fiscal year 2026.

Transcat (TRNS) had a current ratio of 2.33 as of fiscal year 2026, which is generally considered healthy.

Transcat (TRNS) had a debt-to-equity ratio of 0.33 as of fiscal year 2026, measuring the company's financial leverage by comparing total debt to shareholder equity.

Transcat (TRNS) had a return on assets of 1.1% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Transcat (TRNS) has an Altman Z-Score of 4.00, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Transcat (TRNS) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Transcat (TRNS) has an earnings quality ratio of 6.48x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Transcat (TRNS) has an interest coverage ratio of 2.88x, meaning it can adequately cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Transcat (TRNS) scores 56 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top